TRAFFIC ADVISORY:

President Trump is scheduled to be in Philadelphia on Tuesday, September 15, 2020 at The National Constitution Center (NCC) in the Independence Mall area. Increased police presence is anticipated in Center City throughout Tuesday afternoon and evening. Please allow extra time if you are going to Wills Eye. Please be advised of area street closures to vehicles beginning at 1:00PM on Tuesday 9/15. Pedestrian access will also be limited in the area. This is subject to change and area restrictions, which could widen, will be lifted once the President departs the NCC. There are also demonstrations planned for Tuesday 9/15 around Independence Mall as well as City Avenue.

PEDIG Amblyopia Treatment Study

Age Related Macular Degeneration
RESEARCH
Advancing Science • Fostering Collaboration • Inspiring Innovation
Age Related Macular Degeneration
Slider

Pediatric Eye Disease Investigator Group (PEDIG) Amblyopia Treatment Study

Wills Eye Study Doctor: Kammi Gunton, MD

Description

Amblyopia (sometimes called “lazy eye”) is one of the most common causes of permanent decreased vision in children. The purpose of this study is to find out if treating amblyopia with glasses and patching at the same time improves vision as well as treating amblyopia first with glasses and then with patching, if needed.

The study is being conducted by the Pediatric Eye Disease Investigator Group (PEDIG) and is supported through funding from the National Eye Institute of the U.S. National Institutes of Health.

Eligibility

The study will include about 272 children across North America between the ages of 3 to <13 years old with no previous treatment for amblyopia, including glasses or contact lenses. Children eligible for the study will receive prescription eyeglasses and will be assigned to either start the study wearing glasses first (and wear an eye patch for 2 hours each day at a later date if needed) or wearing glasses and patching 2 hours each day at the same time to start. All children will have study visits every 8 weeks for 56 weeks.

Contact

To learn more about the study, please contact:

Kieran Alessi, Wills Eye Pediatric Ophthalmology study coordinator
Email: kalessi@willseye.org
Phone: (267) 428-6146